20174 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals; Nanocapsules; Excipients; Inactive ingredients; Compounds of unknown constitution, e.g. material from plants or animals Virus capsids or envelopes enclosing drugs
MODULAR BACTERIOPHAGE T4 NANOPARTICLE PLATFORM ENABLES RAPID DESIGN OF DUAL COVID-19-FLU MUCOSAL VACCINES
#2VIRUS-LIKE PARTICLES FOR PREVENTING THE SPREADING AND LOWERING THE INFECTION RATE OF VIRUSES
#3EXTRACELLULAR VESICLES AND PARTICLES FROM IMMUNE CELLS FOR PROVIDING ANTICANCER ACTIVITY
#4ATOMIC LAYER DEPOSITION (ALD) PROCESSES APPLIED TO PHAGE AND PHAGE-LIKE PARTICLE PLATFORM YIELD THERMOSTABLE THERAPEUTIC AGENTS
#5ANELLOSOMES FOR DELIVERING SECRETED THERAPEUTIC MODALITIES
#6GENE THERAPY FOR AADC DEFICIENCY
#7PROTEIN-BASED NANOPARTICLE FOR SELF-PACKAGING AND DELIVERING MRNA, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION
#8MODIFIED RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF
#9METHODS AND COMPOSITIONS COMPRISING TOBACCO MILD GREEN MOSAIC VIRUS (TMGMV)
#10DELIVERY OF THERAPEUTIC RECOMBINANT URICASE USING NANOPARTICLES
#11METHODS OF TARGETED DELIVERY TO A HOST USING A CARRIER
#12MELT PROCESSED VIRAL NANOPARTICLE CONSTRUCTS
#13CARRIER FOR LOWERING THE INFECTION RATE OF BACTERIA
#14FACTOR VIII (FVIII) GENE THERAPY METHODS
#15Methods of fabricating carriers for targeted delivery to a host
#16ENGINEERED EXTRACELLULAR VESICLES WITH IMPROVED CARGO DELIVERY
#17Compositions and Methods for Treatment of Diseases Associated with Trinucleotide Repeats in Transcription Factor Four
#18COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
#19COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
#20COMPOSITIONS AND METHODS FOR PRODUCING OREXIN NEUROPEPTIDE USING NANOCAPSULE-BASED DRUG DELIVERY SYSTEM
#21COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH USING NANOCAPSULE-BASED DRUG DELIVERY SYSTEM
#22TREATMENT OF ELEVATED METABOLITE LEVELS USING NANOCARRIERS
#23FORMULATION PROCESS FOR CPMV NANOPARTICLES
#24MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
#25TGF- B receptor II isoform, fusion peptide, methods of treatment and methods in vitro
#26METHOD FOR PRODUCING ALFALFA MOSAIC VIRUS-LIKE PARTICLES USING PLANT EXPRESSION SYSTEM AND USE THEREOF
#27TOBACCO MOSAIC VIRUS DELIVERY OF MITOXANTRONE FOR CANCER THERAPY
#28ANTICANCER DRUG-CONTAINING PLANT VIRUS PARTICLES
#29TARGETED PROTEIN DELIVERY TO MAMMALIAN EMBRYOS AND THERAPEUTIC APPLICATIONS USING EXOSOMES
#30METHODS AND COMPOSITIONS FOR PRODUCING VIRAL FUSOSOMES
#31COMPOSITION, METHOD OF MANUFACTURE, AND USE OF SITE-SPECIFIC DELIVERY OF BRUCEOLIDES FOR TREATMENT OF CANCER AND OTHER DISEASES
#32COMPOSITIONS OF GLYCOPROTEIN PARTICLES
#33mRNA NANOCAPSULE
#34Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules
#35Carrier for targeted delivery to a host
#36GENE THERAPY FOR AADC DEFICIENCY
#37Melt processed viral nanoparticle constructs
#38NOVEL CRISPR ENZYMES AND SYSTEMS
#39COMPOSITIONS OF ENGINEERED EXOSOMES AND METHODS OF LOADING LUMINAL EXOSOMES PAY-LOADS
#40Virus-like particles for preventing the spreading and lowering the infection rate of viruses
#41A METHOD FOR PROVIDING A VLP DERIVED FROM JOHN CUNNINGHAM VIRUS
#42CELL-RECEPTOR TARGETED EXOSOMES
#43NOVEL CRISPR ENZYMES AND SYSTEMS
#44ANELLOSOMES FOR DELIVERING SECRETED THERAPEUTIC MODALITIES
#45TARGETING MICRORNA FOR CANCER TREATMENT
#46MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE
#47PLANT VIRAL NUCLEIC ACID DELIVERY PARTICLES AND USES THEREOF
#48COMPOSITIONS AND METHODS FOR BIOLOGICAL DELIVERY VEHICLES
#49Membrane lipid coated nanoparticles and method of use
#50Virus-like particles for preventing the spreading and lowering the infection rate of viruses
#51PLANT-DERIVED EXTRACELLULAR VESICLE (EVS) COMPOSITIONS AND USES THEREOF
#52COMPOUND DECREASING THE CONCENTRATION OF 2-HYDROXY-GLUTARATE
#53Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acid
#54ADENO-ASSOCIATED VIRUS VECTORS FOR THE DELIVERY OF THERAPEUTICS
#55Drug Delivery Particle and Method for Producing the Same
#56ANELLOSOMES AND METHODS OF USE
#57ANELLOSOMES FOR DELIVERING INTRACELLULAR THERAPEUTIC MODALITIES
#58TGF- RECEPTOR II ISOFORM, FUSION PEPTIDE, METHODS OF TREATMENT AND METHODS IN VITRO
#59Programmable Designer Therapeutic Fusogenic Secreted Gectosome Vesicles For Macromolecule Delivery And Genome Modification
#60BIOMEMBRANE-COVERED NANOPARTICLES (BIONPS) FOR DELIVERING ACTIVE AGENTS TO STEM CELLS
#61Gene therapy for AADC deficiency
#62COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANESTHESIA-INDUCED NEUROTOXICITY
#63Membrane lipid coated nanoparticles and method of use
#64Nanoencapsulated combination drug formulations
#65Use of Microvesicles in the Treatment of Medical Conditions
#66METHODS AND COMPOSITIONS FOR MRNA-BASED MODULATION AND DETECTION OF CELL PHENOTYPES
#67Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acid
#68FORMULATIONS FOR VIROSOMES
#69Polymer-Encapsulated Viral Vectors for Genetic Therapy
#70Methods for treating chondrosarcoma using microrna(miR)
#71Anticancer drug-containing plant virus particles
#72FACTOR VIII (FVIII) GENE THERAPY METHODS
#73Non-immunogenic protein nanoparticles with cancer targeting activity using albumin-binding peptide
#74Crispr enzymes and systems
#75Membrane lipid coated viral nanoparticles and method of use
#76Melt processed viral nanoparticle constructs
#77Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
#78Use of microvesicles in the treatment of medical conditions
#79Compositions and Methods for Treatment of Diseases Associated with Trinucleotide Repeats in Transcription Factor Four
#80ROD-SHAPED PLANT VIRAL NANOPARTICLES OR VIRUS-LIKE PARTICLES FOR AGRICULTURAL APPLICATIONS
#81TGF-receptor II isoform, fusion peptide, methods of treatment and methods in vitro
#82VIRAL VECTOR NANOCAPSULE FOR TARGETING GENE THERAPY AND ITS PREPARATION
#83Combination preparation including a corticosteroid and exosomes
#84Anticancer drug-containing plant virus particles
#85Gene therapy for AADC deficiency
#86SYSTEMS AND METHODS OF DELIVERY OF BIOACTIVE AGENTS USING BACTERIAL TOXIN-DERIVED TRANSPORT SEQUENCES
#87Composition, method of manufacture, and use of site-specific delivery of bruceolides for treatment of cancer and other diseases
#88METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS
#89Materials and methods for modulation of tendon healing
#90Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
#91Compositions and methods using capsids resistant to hydrolases
#92Nanocapsules carrying chikungunya-associated peptides
#93High density lipoprotein nanoparticles for inflammation
#94Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
#95THERMOSTABLE, CHROMATOGRAPHICALLY PURIFIED NANO-VLP VACCINE
#96Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof
#97Drug delivery particle and method for producing the same
#98SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM
#99rAAV vectors and methods for transduction of photoreceptors and RPE cells
#100Precise delivery of therapeutic agents to cell mitochondria for anti-cancer therapy
#101Materials and methods for modulation of tendon healing
#102FORMULATIONS FOR VIROSOMES
#103METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS
#104Compositions and methods using capsids resistant to hydrolases
#105Tetrary gene delivery system for gene therapy and methods of its use
#106Viral vector nanocapsule for targeting gene therapy and its preparation
#107METHODS AND COMPOSITIONS FOR CONTROLLING ASSEMBLY OF VIRAL PROTEINS
#108Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
#109Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
#110Immunogenic compositions and methods therefor
#111Polypeptides and vectors for targeting HER2/expressing cells and uses thereof
#112Drug delivery particle and method for producing the same
#113Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease
#114Preparation of microvesicle-siRNA complexes and use thereof in AIDS treatment
#115Use of microvesicles in the treatment of medical conditions
#116Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
#117Composition comprising interleukin-1 receptor antagonist and corticosteroid
#118Methods and compositions for controlling assembly of viral proteins
#119Recombinant protein for intracellular delivery of siRNA and composition comprising the same
#120Virion Derived Protein Nanoparticles For Delivering Radioisotopes For The Diagnosis And Treatment Of Malignant And Systemic Disease And The Monitoring Of Therapy
#121SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM
#122Tetrary gene delivery system for gene therapy and methods of its use
#123Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
#124Combination preparation including a corticosteroid and exosomes
#125COMBINATION PREPARATION INCLUDING A CYTOKINE ANTAGONIST AND CORTICOSTEROID
#126PRODUCTION OF VIRAL CAPSIDS
#127CONSTRUCT COATED WITH VIRUS COAT-CONSTITUTING PROTEIN AND METHOD FOR PRODUCING SAME
#128Viral nanoparticle cell-targeted delivery platform
#129Biodegradable non-woven fabric having plant virus encapsulated actives for drug delivery
#130SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM
#131Hydrogels with network defects enhanced by nanoparticle incorporation
#132RNA VECTOR THERAPY METHOD
#133CHEMO VECTOR THERAPY TO DELIVER CHEMOTHERAPY MOLECULES TO SPECIFIC CELLS TO MANAGE BREAST CANCER, OTHER CANCERS AND INFLAMMATORY DISORDERS
#134CONFIGURABLE MICROSCOPIC MEDICAL PAYLOAD DELIVERY DEVICE TO DELIVER MEDICALLY THERAPEUTIC PAYLOADS TO SPECIFICALLY TARGETED CELL TYPES
#135Antiviral agent
#136Chemically Modified Viral Capsids as Targeted Delivery Vectors for Diagnostic and Therapeutic Agents
#137HOLLOW NANOPARTICLES AND USES THEREOF
#138Protection of virus particles from phagocytosis by expression of CD47
#139Virus-modified bacteria ghosts
#140Protein-Modified Nano-Droplets, Compositions and Methods of Production
#141Encapsidation of heterologous entities into virus-like particles
#142Methods of treating Parkinson's disease using viral vectors
#143Process for producing modified reconstituted sendai viral envelope specific for drug and/or gene delivery to liver cells
#144Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant
#145Self-assembling nanoparticle drug delivery system
#146Virus coated nanoparticles and uses thereof
#147Protein Delivery System
#148Vesicular monoamine transporter gene therapy in Parkinson's disease
#149Composition having antitumor effect
#150Targeted artificial gene delivery
#151Compositions and methods for treating B-cell malignancies
#152NOVEL NANOPARTICLES AND USE THEREOF
#153Substance carrier using hollow nanoparticle of hepatitis B virus protein and liposome, and method of introducing substance into cell
#154Self-assembling nanoparticle drug delivery system
#155Hollow nanoparticles of protein and drug using the same
#156Chemotherapeutic agent-incorporated pharmaceutical preparation
#157Hollow nanoparticle of NBsAg large protein for drug delivery
#158Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#159Methods of treating parkinson's disease using viral vectors